Predictor at ART initiation | HR, 95% CI | P value | Model 1 adjusted HR, 95% CI | P value | Model 2 Adjusted HR, 95% CI | P value |
---|---|---|---|---|---|---|
Age (years) | 1.04 (0.90 − 1.21) | 0.57 |  |  |  |  |
BMI (kg/m2) | 0.94 (0.78–1.14) | 0.56 |  |  |  |  |
Karnofsky Performance Scale | Â | Â | Â | Â | Â | Â |
  Minor symptoms (90) | Reference |  |  |  |  |  |
  Moderate symptoms (80) | 1.11 (0.11–10.63) | 0.93 |  |  |  |  |
  Unable to work (<80) | 5.34 (0.55–51.38) | 0.15 |  |  |  |  |
  Current tuberculosis | 3.01 (0.50–18.02) | 0.23 |  |  |  |  |
WHO Stage | Â | Â | Â | Â | Â | Â |
  Stage I | Reference |  |  |  |  |  |
  Stage II | 0.66 (0.04–10.49) | 0.77 |  |  |  |  |
  Stage III | 0.85 (0.08–9.34) | 0.89 |  |  |  |  |
  Stage IV | 1.80 (0.11–28.77) | 0.68 |  |  |  |  |
CD4 Cell count (cells/μL) | 0.99 (0.97–1.01) | 0.22 |  |  |  |  |
Log10 Plasma HIV-1 RNA (copies/mL) | 3.00 (0.62–14.60) | 0.17 |  |  |  |  |
Hemoglobin (g/dL) | 0.59 (0.33–1.07) | 0.08 | 0.51 (0.21–1.23) | 0.13 | 0.41 (0.18–0.92) | 0.03 |
Log10 Angiopoietin-1 (ng/mL) | 0.25 (0.005–13.63) | 0.50 |  |  |  |  |
Log10 Angiopoietin-2 (ng/mL) | 18.85 (1.52–233.7) | 0.02 | 41.31 (0.82–2,086) | 0.06 | 75.06 (1.98–2,846) | 0.02 |
Log10 ANG-2/ANG-1 ratio | 19.99 (1.66–240.5) | 0.02 |  |  |  |  |
Log10 s-ICAM (ng/mL) | 10,062 (18.29–5,536,091) | 0.004 | 355.8 (0.22–581,538) | 0.12 |  |  |
Log10 E-selectin (ng/mL) | 11.17 (0.18–696.4) | 0.25 |  |  |  |  |
Log10 VCAM (ng/mL) | 9.33 (0.14–644.0) | 0.30 |  |  |  |  |